Cutaneous T-cell lymphoma: diagnosing subtypes and the challenges

Area of Science:

• Oncology
• Dermatology
• Hematology

Background:

• Cutaneous T-cell lymphoma (CTCL) is a rare extranodal non-Hodgkin's lymphoma primarily affecting the skin.
• Its uncertain pathogenesis and variable clinical presentation pose diagnostic and management challenges.
• CTCL is a chronic, relapsing illness requiring symptomatic relief and quality of life improvement.

Purpose of the Study:

• To provide an overview of mycosis fungoides and Sézary syndrome, the two main subtypes of CTCL.
• To review clinical presentation, histopathological correlation, and diagnostic challenges.
• To highlight the importance of accurate diagnosis and early specialist involvement for improved patient outcomes.

Main Methods:

• Review of clinical presentation and histopathological findings in CTCL.
• Analysis of diagnostic challenges in early and advanced stages.
• Discussion of current treatment aims and emerging novel agents.

Main Results:

• Early-stage CTCL often follows an indolent course, mimicking benign dermatological conditions, leading to diagnostic delays.
• Advanced-stage CTCL has a poor prognosis with significant morbidity.
• Accurate diagnosis and prompt specialist team involvement are paramount for effective management.

Conclusions:

• Accurate diagnosis and early specialist intervention are critical for managing cutaneous T-cell lymphoma.
• Improving patient outcomes and quality of life are key treatment goals.
• Novel therapeutic agents show promise for enhancing prognosis and patient well-being.